With over 35 years of expertise in the In Vitro Diagnostics (IVD) industry, Advy is a leading manufacturer of native human antigens, polyclonal antibodies, and rapid diagnostic kits. Our commitment to innovation and quality has positioned us as a trusted partner to IVD manufacturers globally, with exports reaching the USA, Europe, Japan, and China. Our Malaria RDT has achieved WHO prequalification, meeting stringent performance and quality standards. We are actively expanding our rapid diagnostic portfolio to address a broader range of infectious diseases, reinforcing our commitment to global health. Our mission is to work collaboratively with our partners worldwide to address unmet clinical needs in diagnostics and life sciences.
AdvaHealth Solutions
Break free from legacy PACS limitations with AdvaPACS, the fully cloud-native platform from AdvaHealth Solutions. Modernize your radiology workflow with automation, unified portals, AI readiness, unlimited users, and flexible pricing—deployable in just 15 minutes.
Admera Health
Admera Health is a trusted partner in advanced genomic and bioinformatic services to empower researchers with data-driven insights. Operating in a CLIA/CLEP-certified and CAP-accredited environment using state-of-the-art NGS technology, we offer a comprehensive suite of cutting-edge solutions to deliver high-resolution insights for oncology and drug discovery. From high-throughput gene expression screening and CRISPR sequencing to multi-omic spatial mapping, our expert team equipping scientists to identify biomarkers and accelerate therapeutics with unparalleled data quality and speed.
Adaptix
Adaptix Limited is transforming radiology through the development of innovative 3D imaging technologies that are significantly better, safer, smaller, and more affordable than traditional radiology systems. The technology has applications across a multitude of global markets that are currently limited to 2D X-ray imaging systems where cost, speed to diagnostic result, location, or dose concerns, mean CT is not optimal. | Adaptix Limited is transforming radiology through the development of innovative 3D imaging technologies that are significantly better, safer, smaller, and more affordable than traditional radiology systems. The technology has applications across a multitude of global markets that are currently limited to 2D X-ray imaging systems where cost, speed to diagnostic result, location, or dose concerns, mean CT is not optimal. Adaptix’s central mission is to transform radiology by offering affordable low-dose 3D imaging at the point-of-care and allowing “3D-first” as the standard of care.
ActivInsights
ActivInsights is a Digital Health company. ActivInsights delivers activity, sleep and lifestyle insight to healthcare professionals. We simplify access to real-world patient data with our wearables, connected technologies and secure data infrastructure. With a commitment to improving global public health, ActivInsights is accelerating pharmaceutical drug development, enhancing clinical practice and improving disease management. Our high resolution wearable technologies are designed to be very low burden for long-term continuous wear for participants. We offer a true, unfiltered tri-axial raw data acceleroemeter, the GENEActiv, and a near-real time device, the Activinsights Band for long-term wear. The wearables achieve high compliance and adherence, are cost-effective and enable objective insights into physical activity, gait and mobility, sleep, lifestyle and disease progression. Babies as young as 8 weeks old have worn the devices, up to older adults on the wrist. ActivInsights technologies can be deployed in an array of therapeutic areas to truly understand the patient’s wellbeing in a free living environment, outside of the clinic. We offer seamless integration into existing platforms and can support data processing and analysis services to deliver meaningful digital biomarkers and objective outcome assessments.
AcouSort AB
AcouSort is an innovative technology company with high focus on products and solutions for automated preparation of biological samples for researchers and life science companies. The core technology is acoustofluidics where a combination of microfluidics and sound waves is used to separate blood into its components, to isolate and purify cells and extracellular vesicles and to perform rapid biochemical reactions. AcouSort’s core technology has been researched and developed for over 20 years at Lund University in the Department of Biomedical Engineering, research headed by Professor Thomas Laurell, board member of AcouSort. | AcouSort is an innovative technology company with high focus on products and solutions for automated preparation of biological samples for researchers and life science companies. The core technology is acoustofluidics where a combination of microfluidics and sound waves is used to separate blood into its components, to isolate and purify cells and extracellular vesicles and to perform rapid biochemical reactions. AcouSort works with life science system providers integrating its automated sample processing technology into their next generation PoC dignostics or cell therapy systems. The first result of such partnerships recieved FDA and other authority approvals in 2023. AcouSort’s core technology has been researched and developed for over 20 years at Lund University in the Department of Biomedical Engineering, research headed by Professor Thomas Laurell, board member of AcouSort. | AcouSort provides game changing sample processing solutions for the life science and diagnostic industry. AcouSort provides solutions for diagnostic applications and cell therapy manufacturing enabling automated and integrated sample processing of cells and extracellular vesicles. Our acoustofluidic products enable automation and integration of washing, enrichment, up-concentration, optical or physical separation, and more – all while providing superior sample quality.
ACD, a Bio-Techne brand
Bio-Techne’s leading spatial biology brands, ACD and Lunaphore, are transforming the future of research and precision medicine. From low-plex chromogenic to high-plex fluorescent assays, the scalable platforms and fully automated same-section multiomics workflows bring unmatched performance and flexibility to scientists. Powered by the gold-standard RNAscope™ technology & Lunaphore’s flagship end-to-end fully automated COMET™ product suite, Bio-Techne equip researchers with the right tools!
AB DigiHealth Inc.
AB DigiHealth Inc. stands as a pioneering, modern core laboratory dedicated to advancing genomic research. Originating as a startup from Center for Genomic Medicine, National Cheng Kung University in Taiwan, our mission is to bridge the gap between scientific discoveries and clinical applications, providing a comprehensive solution for maternal-fetal precision medicine to the world. Harnessing state-of-the-art Next-Generation Sequencing (NGS) technology, advanced bioinformatics, and AI predictive algorithms, our goal is to usher prenatal genetic testing into a new era. As guardians of maternal-fetal health, we endeavor to create an efficient, empowering digital solution that leverages cloud-based NGS analytics pipelines and AI-based companion diagnosis. Our vision is to establish a next-generation healthcare system characterized by high accuracy, enhancing operational efficiency in laboratories and clinics.
4DMedical
4DMedical is a global leader in innovative respiratory and cardiopulmonary imaging software. Our SaaS solutions deliver non-invasive, regional, and lobar quantitative lung function analysis—giving pulmonologists and clinicians the power to act sooner and with objective data for patients with unexplained dyspnea, asthma, COPD, and other lung diseases. We also support early intervention with low-dose lung health screenings and physician-customized smoking cessation tools to help prevent disease progression. 4DMedical’s CT:VQ™ is the world’s first and only non-contrast post-processing technology that transforms routine chest CT scans into detailed, quantitative maps of lung ventilation (V) and perfusion (Q), all without injected contrast or radioisotopes. CT:VQ™ seamlessly fits into your existing workflow, delivering results directly for rapid interpretation—all from the CT you already order. You can act sooner with objective perfusion data—from the CT you already order. Enhance patient care with actionable functional data from every chest CT—accelerating your path from suspicion to confident clinical decision. | 4DMedical is a global leader in innovative respiratory and cardiopulmonary imaging software. Using advanced, non-invasive CT imaging technology, our SaaS offerings provide non-invasive, regional and lobar quantitative lung function analysis for unparalleled insights into cardiopulmonary health. With a single CT lung scan, 4DMedical provides automated, quantitative analysis that equips radiologists with detailed insights to support ordering physicians in delivering optimal patient care. Now available: CT:VQ™ is the world’s first and only non-contrast post-processing technology that transforms routine chest CT scans into quantitative, lobar ventilation (V) and perfusion (Q) maps—without contrast media, inhaled agents, or added scan time. Results are automatically delivered to PACS, ready for radiologist interpretation alongside the source CT images. For Radiologists: – One modality, one department: Complete pulmonary imaging with no new hardware or workflow steps – Add objective, functional metrics to every routine CT – Improve reporting consistency and inter-reader reproducibility – Automated, quantitative reporting and seamless PACS integration – Peer-reviewed, proven correlation with spirometry and radiologist-based metrics – Enhance your CT utility—structure and function, together in a single exam With 4DMedical, radiologists can deliver both structural and functional lung, and cardiac assessment from standard CT, enhancing diagnostic confidence, improving report value, and streamlining workflow efficiency.